Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Jan 2, 2009

Premium
Daniel Liebler, a professor of biochemistry at Vanderbilt University, has been elected a fellow of the American Association for the Advancement of Science, bestowed upon scientists for their efforts to advance science or its applications that are deemed scientifically or socially distinguished, the school reported last month.
 
Leibler is the director of the Proteomics Center and the Jim Ayers Institute for Pre-Cancer Detection and Diagnosis and was cited for “distinguished contributions to the development of proteomics and applications to mechanistic toxicology.”
 
He is also a group leader in the National Cancer Institute’s Clinical Proteomic Technology Assessment for Cancer program.
 

 
President-elect Barack Obama has selected Broad Institute Founding Director Eric Lander and former National Institutes of Health Director Harold Varmus to serve as co-chairs for the President’s Council of Advisors on Science and Technology.
 
The two appointees were named along with two other high-ranking members of Obama’s science and technology team.
 
John Holdren, the director of the Program on Science, Technology, and Public Policy at Harvard’s Kennedy School of Government, has agreed to serve as assistant to the president for science and technology and to be director of the White House Office of Science and Technology Policy. Holdren also is a former president and chairman of the board of the American Association for the Advancement of Science.
 
Obama also nominated Jane Lubchenco to serve as administrator for the National Oceanic and Atmospheric Administration. Lubchenco is a past-president of the International Council for Science and a former president of AAAS.
 
“It’s time we once again put science at the top of our agenda and worked to restore America’s place as the world leader in science and technology,” Obama said in a statement.
 
Noting that Lander was “one of the driving forces behind mapping the human genome,” Obama said he will be “a powerful voice in my Administration as we seek to find the causes and cures of our most devastating diseases.”

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.